Skip to Main content Skip to Navigation
Journal articles

Trial Design Principles for Patients at High Bleeding Risk Undergoing PCI

Abstract : Investigating the balance of risk for thrombotic and bleeding events after percutaneous coronary intervention (PCI) is especially relevant for patients at high bleeding risk (HBR). The Academic Research Consortium for HBR recently proposed a consensus definition in an effort to standardize the patient population included in HBR trials. The aim of this consensus-based document, the second initiative from the Academic Research Consortium for HBR, is to propose recommendations to guide the design of clinical trials of devices and drugs in HBR patients undergoing PCI. The authors discuss the designs of trials in HBR patients undergoing PCI and various aspects of trial design specific to HBR patients, including target populations, intervention and control groups, primary and secondary outcomes, and timing of endpoint reporting. (C) 2020 by the American College of Cardiology Foundation.
Document type :
Journal articles
Complete list of metadata

https://hal.inrae.fr/hal-03156943
Contributor : Nelly Lucas <>
Submitted on : Thursday, March 11, 2021 - 10:46:42 AM
Last modification on : Thursday, March 11, 2021 - 8:09:45 PM
Long-term archiving on: : Saturday, June 12, 2021 - 6:24:08 PM

File

capodanno2020.pdf
Files produced by the author(s)

Licence


Distributed under a Creative Commons Attribution 4.0 International License

Identifiers

Collections

Citation

Davide Capodanno, Marie-Claude Morice, Dominick Angiolillo, Deepak Bhatt, Robert Byrne, et al.. Trial Design Principles for Patients at High Bleeding Risk Undergoing PCI. Journal of the American College of Cardiology, Elsevier, 2020, 76 (12), pp.1468-1483. ⟨10.1016/j.jacc.2020.06.085⟩. ⟨hal-03156943⟩

Share

Metrics

Record views

36

Files downloads

68